"Designing Growth Strategies is in our DNA"

Veterinary Oncology Market Size, Share & Industry Analysis, By Offering (Diagnostics {By Product [Instruments and Reagents & Consumables], By Technique [Cytology, Hematology, Clinical Biochemistry, and Others]} and Therapeutics {By Drug Class [Cytotoxic Chemotherapy Drugs, Targeted Anticancer Drugs, and Others], By Therapy Type [Targeted Therapy, Chemotherapy, Immunotherapy, and Others]}), By Cancer Type (Lymphoma, Mast Cell Tumor, Melanoma, Osteosarcoma, Mammary Tumors, and Others), By Animal Type (Canine, Feline, Equine, and Others), and Regional Forecast, 2026-2034

Last Updated: June 12, 2026 | Format: PDF | Report ID: FBI117236

 

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges
    5. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, By Key Countries/Region, 2025
    2. Pipeline Analysis, By Key Players
    3. Overview: Advancements in Veterinary Diagnostics
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
    5. New Product Launches, By Key Players
  5. Global Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy 
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy 
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of the Middle East & Africa
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. IDEXX Laboratories, Inc.
      2. Zoetis Services LLC.
      3. Antech Diagnostics, Inc
      4. Volition
      5. Elanco
      6. Dechra Limited
      7. Boehringer Ingelheim International GmbH
      8. Oncotect 
      9. Virbac
      10. Novavive Inc.
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges
    5. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, By Key Countries/Region, 2025
    2. Pipeline Analysis, By Key Players
    3. Overview: Advancements in Veterinary Diagnostics
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
    5. New Product Launches, By Key Players
  5. Global Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy 
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Veterinary Oncology Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Offering
      1. Diagnostics
        1. By Product
          1. Instruments
          2. Reagents & Consumables
        2. By Technique
          1. Cytology
          2. Histopathology / Anatomic Pathology
          3. Hematology
          4. Clinical Biochemistry
          5. Immunodiagnostics
          6. Molecular Diagnostics
          7. Others
      2. Therapeutics
        1. By Drug Class
          1. Cytotoxic Chemotherapy Drugs
          2. Targeted Anticancer Drugs
          3. Cancer Vaccines
          4. Hormonal Drugs
          5. Corticosteroids
          6. Others
        2. By Therapy Type
          1. Targeted Therapy
          2. Chemotherapy 
          3. Immunotherapy
          4. Others
    2. Market Analysis, Insights and Forecast – By Cancer Type
      1. Lymphoma
      2. Mast Cell Tumor
      3. Melanoma
      4. Osteosarcoma
      5. Mammary Tumors
      6. Soft Tissue Sarcoma
      7. Hemangiosarcoma
      8. Squamous Cell Carcinoma
      9. Others
    3. Market Analysis, Insights and Forecast – By Animal Type
      1. Canine
      2. Feline
      3. Equine
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of the Middle East & Africa
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. IDEXX Laboratories, Inc.
      2. Zoetis Services LLC.
      3. Antech Diagnostics, Inc
      4. Volition
      5. Elanco
      6. Dechra Limited
      7. Boehringer Ingelheim International GmbH
      8. Oncotect 
      9. Virbac
      10. Novavive Inc.
Read Less

Figure 1:  Global Veterinary Oncology Market Revenue Breakdown (USD Billion, %) By Region, 2025 & 2034

Figure 2:  Global Veterinary Oncology Market Value Share (%), By Offering, 2025 & 2034

Figure 3:  Global Veterinary Oncology Market Value Share (%), By Cancer Type, 2025 & 2034

Figure 4:  Global Veterinary Oncology Market Value Share (%), By Animal Type, 2025 & 2034

Figure 5:  Global Veterinary Oncology Market Value Share (%), By Region, 2025 & 2034

Figure 6:  North America Veterinary Oncology Market Value (USD Billion), By Offering, 2025 & 2034

Figure 7:  North America Veterinary Oncology Market Value Share (%), By Offering, 2025

Figure 8:  North America Veterinary Oncology Market Value (USD Billion), By Cancer Type, 2025 & 2034

Figure 9:  North America Veterinary Oncology Market Value Share (%), By Cancer Type, 2025

Figure 10:  North America Veterinary Oncology Market Value (USD Billion), By Animal Type, 2025 & 2034

Figure 11:  North America Veterinary Oncology Market Value Share (%), By Animal Type, 2025

Figure 12:  North America Veterinary Oncology Market Value (USD Billion), By Country, 2025 & 2034

Figure 13:  North America Veterinary Oncology Market Value Share (%), By Country, 2025

Figure 14:  Europe Veterinary Oncology Market Value (USD Billion), By Offering, 2025 & 2034

Figure 15:  Europe Veterinary Oncology Market Value Share (%), By Offering, 2025

Figure 16:  Europe Veterinary Oncology Market Value (USD Billion), By Cancer Type, 2025 & 2034

Figure 17:  Europe Veterinary Oncology Market Value Share (%), By Cancer Type, 2025

Figure 18:  Europe Veterinary Oncology Market Value (USD Billion), By Animal Type, 2025 & 2034

Figure 19:  Europe Veterinary Oncology Market Value Share (%), By Animal Type, 2025

Figure 20:  Europe Veterinary Oncology Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 21:  Europe Veterinary Oncology Market Value Share (%), By Country/ Sub-region, 2025

Figure 22:  Asia Pacific Veterinary Oncology Market Value (USD Billion), By Offering, 2025 & 2034

Figure 23:  Asia Pacific Veterinary Oncology Market Value Share (%), By Offering, 2025

Figure 24:  Asia Pacific Veterinary Oncology Market Value (USD Billion), By Cancer Type, 2025 & 2034

Figure 25:  Asia Pacific Veterinary Oncology Market Value Share (%), By Cancer Type, 2025

Figure 26:  Asia Pacific Veterinary Oncology Market Value (USD Billion), By Animal Type, 2025 & 2034

Figure 27:  Asia Pacific Veterinary Oncology Market Value Share (%), By Animal Type, 2025

Figure 28:  Asia Pacific Veterinary Oncology Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 29:  Asia Pacific Veterinary Oncology Market Value Share (%), By Country/ Sub-region, 2025

Figure 30:  Latin America Veterinary Oncology Market Value (USD Billion), By Offering, 2025 & 2034

Figure 31:  Latin America Veterinary Oncology Market Value Share (%), By Offering, 2025

Figure 32:  Latin America Veterinary Oncology Market Value (USD Billion), By Cancer Type, 2025 & 2034

Figure 33:  Latin America Veterinary Oncology Market Value Share (%), By Cancer Type, 2025

Figure 34:  Latin America Veterinary Oncology Market Value (USD Billion), By Animal Type, 2025 & 2034

Figure 35:  Latin America Veterinary Oncology Market Value Share (%), By Animal Type, 2025

Figure 36:  Latin America Veterinary Oncology Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 37:  Latin America Veterinary Oncology Market Value Share (%), By Country/ Sub-region, 2025

Figure 38:  Middle East & Africa Veterinary Oncology Market Value (USD Billion), By Offering, 2025 & 2034

Figure 39:  Middle East & Africa Veterinary Oncology Market Value Share (%), By Offering, 2025

Figure 40:  Middle East & Africa Veterinary Oncology Market Value (USD Billion), By Cancer Type, 2025 & 2034

Figure 41:  Middle East & Africa Veterinary Oncology Market Value Share (%), By Cancer Type, 2025

Figure 42:  Middle East & Africa Veterinary Oncology Market Value (USD Billion), By Animal Type, 2025 & 2034

Figure 43:  Middle East & Africa Veterinary Oncology Market Value Share (%), By Animal Type, 2025

Figure 44:  Middle East & Africa Veterinary Oncology Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034

Figure 45:  Middle East & Africa Veterinary Oncology Market Value Share (%), By Country/ Sub-region, 2025

Figure 46:  Global Veterinary Oncology Market Share (%), by Company, 2025

Table 1:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Offering, 2021-2034 

Table 2:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Diagnostics, 2021-2034 

Table 3:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Product, 2021-2034 

Table 4:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Technique, 2021-2034 

Table 5:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapeutics, 2021-2034 

Table 6:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Drug Class, 2021-2034 

Table 7:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapy Type, 2021-2034 

Table 8:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Cancer Type, 2021-2034 

Table 9:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Animal Type, 2021-2034 

Table 10:  Global Veterinary Oncology Market Revenue (USD Billion) Forecast, By Region, 2021-2034 

Table 11:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Offering, 2021-2034 

Table 12:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Diagnostics, 2021-2034 

Table 13:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Product, 2021-2034 

Table 14:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Technique, 2021-2034 

Table 15:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapeutics, 2021-2034 

Table 16:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Drug Class, 2021-2034 

Table 17:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapy Type, 2021-2034 

Table 18:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Cancer Type, 2021-2034 

Table 19:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Animal Type, 2021-2034 

Table 20:  North America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Country, 2021-2034 

Table 21:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Offering, 2021-2034 

Table 22:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Diagnostics, 2021-2034 

Table 23:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Product, 2021-2034 

Table 24:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Technique, 2021-2034 

Table 25:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapeutics, 2021-2034 

Table 26:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Drug Class, 2021-2034 

Table 27:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapy Type, 2021-2034 

Table 28:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Cancer Type, 2021-2034 

Table 29:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Animal Type, 2021-2034 

Table 30:  Europe Veterinary Oncology Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034 

Table 31:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Offering, 2021-2034 

Table 32:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Diagnostics, 2021-2034 

Table 33:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Product, 2021-2034 

Table 34:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Technique, 2021-2034 

Table 35:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapeutics, 2021-2034 

Table 36:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Drug Class, 2021-2034 

Table 37:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapy Type, 2021-2034 

Table 38:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Cancer Type, 2021-2034 

Table 39:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Animal Type, 2021-2034 

Table 40:  Asia Pacific Veterinary Oncology Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034 

Table 41:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Offering, 2021-2034

Table 42:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Diagnostics, 2021-2034 

Table 43:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Product, 2021-2034 

Table 44:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Technique, 2021-2034 

Table 45:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapeutics, 2021-2034 

Table 46:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Drug Class, 2021-2034 

Table 47:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapy Type, 2021-2034 

Table 48:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Cancer Type, 2021-2034 

Table 49:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Animal Type, 2021-2034 

Table 50:  Latin America Veterinary Oncology Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034 

Table 51:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Offering, 2021-2034 

Table 52:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Diagnostics, 2021-2034 

Table 53:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Product, 2021-2034 

Table 54:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Technique, 2021-2034 

Table 55:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapeutics, 2021-2034 

Table 56:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Drug Class, 2021-2034 

Table 57:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Therapy Type, 2021-2034 

Table 58:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Cancer Type, 2021-2034 

Table 59:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Animal Type, 2021-2034 

Table 60:  Middle East & Africa Veterinary Oncology Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034 

Veterinary Oncology Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 214
Download Free Sample

    man icon
    Mail icon
    Captcha refresh

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Customize Now
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports